Steminent Biotherapeutics Inc. is set to present Stemchymal®, its lead investigational therapy, at the World Orphan Drug ...

Steminent Biotherapeutics specializes in developing innovative stem cell-based therapeutics that offer new hope for patients ...

This valuable investigation provides new and solid evidence for a specific cognitive deficit in cerebellar degeneration patients. The authors use three tasks that modulate complexity and error ...

The Specialty Coffee Association (SCA) has announced the World Coffee Championships 2026 will take place in Panama and California, United States. On 9 April, the SCA confirmed the 2026 World Barista ...

The Specialty Coffee Association (SCA) has announced that the World Coffee Championships 2026 will take place at World of Coffee Panama and World of Coffee San Diego. On 9 April, SCA confirmed the ...

According to reporting by Equus, the condition has been named Equine Juvenile Spinocerebellar Ataxia and was discovered in offspring of the same, unnamed sire. Foals with the disease were born ...

Lexeo Therapeutics, Inc, a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, announced positive interim data across all dose cohorts of ...

The victory avenged a loss in a 4-inning contest against the Lady Tigers’ namesakes from Dent County in the second annual SCA Tournament March 29 at Mountain Grove. “We hit it well,” said ...

Lexeo Therapeutics has posted updated data in Friedreich ataxia (FA) patients, linking a gene therapy to improvements on outcomes the biotech plans to use as co-primary endpoints in a ...

Friedreich’s ataxia (FA) is a neurodegenerative disease most people have never heard of, and it remains widely misunderstood —and for the hundreds of Canadians who live with it, the lack of ...

At the 2025 AMCP annual meeting in Houston from March 31 to April 3, John M. O'Brien, Pharm.D., MPH, president and CEO of the National Pharmaceutical Council (NPC), shared concerns and potential ...